CD80 and neoplasm: Originally identified as a T cell co-stimulatory molecule, CD276 (B7 family) expression on tumor cells was found to prevent T cell and NK cell activity (61) In addition, similar to our observation, high tumoral CD276 expression correlated with poor outcome as well (62).